March 2026. More for You ...

Novo Nordisk NOVO.B5.96%increase; green up pointing triangle plans to slash U.S. list prices for its popular weight-loss and diabetes drugs Wegovy and Ozempic by up to half starting next year. Under ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.

Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...

Citi Research has trimmed its year-end target for India's Nifty 50, citing mounting risks to growth and corporate earnings and as surging oil and supply shocks from the escalating Middle East war ...

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and ...

Megan Thee Stallion celebrated her 31st birthday with a sun-soaked trip to the British Virgin Islands, posing here in a Jaded London dress with daring cutouts. Instagram/theestallion Megan Thee ...

It’s a hot girl whip. Klay Thompson celebrated Megan Thee Stallion’s 31st birthday, which she marked on Sunday, by gifting her a baby blue Bentley. According to a Bentley dealership — which is not the ...

Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines for COVID-19 and shingles, migraine treatments, and blockbuster cancer drugs, according to data ...

December saw a broad mix of low- to mid-single-digit HVACR price adjustments, with several manufacturers implementing category-specific increases that vary by item. Most changes fall in the 2-8% range ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Elaine Chen covers biotech, ...